Project Grant K08CA293156
- This federal Project Grant award, totaling $477,869.00, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395). The grant aims to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women, including African American women and Black African immigrant women. The key objectives are to: 1) identify multilevel determinants of routine cervical cancer screening and follow-up adherence among these populations,...
- This federal Project Grant award of $126,738 was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The award was granted to the University of California, Davis to implement a community-based cancer prevention intervention focused on improving breast cancer screening rates among a marginalized population experiencing food insecurity. The key goals of the project are to: 1) Identify barriers and facilitators to implementing a cancer...
- This $113,928 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support Kelsey Sinclair, the Principal Investigator, in advancing her research training towards becoming an independent cancer multimorbidity scientist. The project aims to identify risk and protective factors for obesity among Black breast cancer survivors, a population with high mortality rates partially attributed to obesity comorbidities. The multi-method study will...
- This federal Project Grant award of $505,613, provided by the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research), will support the development of statistical and computational approaches to harness genomic data and translate findings into precision prevention strategies for cancer. The key objectives are to: Develop deep learning-based methods to identify tumor subtypes linked to adverse outcomes and robust data integration approaches to assess associations between...
- This federal Project Grant award for $279,411.00 was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant, awarded to the University of Washington on March 17, 2025, will support research to examine epigenetic changes during breast cancer treatment and their association with changes in exercise capacity and cardiac function. The study will leverage samples from the NCI-funded UPBEAT study to quantify DNA methylation as...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $132,825 to the Sloan-Kettering Institute for Cancer Research to develop and validate prognostic models for Black women with endometrial cancer following hysterectomy. The key products and services to be delivered include: Building a robust prognostic tool tailored for Black endometrial cancer patients to predict 3- and 5-year post-hysterectomy survival using clinical and epidemiological...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $547,047 to Georgetown University to conduct a clinical trial testing the bundling of multicancer screening and genetic services navigation to improve cancer health equity among Black and Hispanic women. The project aims to address patient- and organization-level barriers that limit cancer screening and genetic testing rates in these populations, which experience...
- The University of Alabama at Birmingham (UAB) received a $192,780 Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) to implement and optimize a bundled screening program for breast and cervical cancer in a resource-limited setting in sub-Saharan Africa. The project aims to 1) establish the reach and effectiveness of the bundled screening program across stationary and mobile clinics, and 2) identify the implementation outcomes of...
- This $714,062 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) is supporting research at the University of California, San Francisco (UCSF) to investigate the biological mechanisms contributing to racial disparities in oral and head and neck cancer outcomes, particularly among Black patients. The key research objectives are to: 1) develop a tailored RNA prognostic model to enhance oral cancer survival predictions in Black populations by identifying...
- The National Cancer Institute awarded a $197,747 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of North Carolina at Chapel Hill. The grant, titled "IMPROVING AFFORDABILITY IN CANCER CARE THROUGH ECONOMIC SCREENING AND SUPPORT (I-ACCESS)", aims to pilot and refine a screening assessment and referral program to proactively identify cancer-related financial hardship in patients and connect them with financial education, counseling, and resources....
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) will provide $278,494 to the University of Washington from August 1, 2025 to July 31, 2030. The purpose of the grant is to design, implement, and evaluate an intervention to promote patient portal use among Black women in order to lower barriers to breast cancer screening. The project aims to: 1) determine facilitators and barriers for portal use to facilitate breast cancer screening among Black women, 2) co-design an adaptive (multi-phase) intervention to improve portal access and uptake to facilitate screening, and 3) pilot and evaluate the adaptive intervention. This award supports the training and research experience needed for the principal investigator to become an independent clinician investigator in developing and evaluating interventions to address cancer screening inequities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $278.5k | 7/30/25 |